Dignio
Dignio AS is a Norwegian health tech company that sells a CE-marked, unified remote patient monitoring and electronic medication dispensing platform (Dignio Connected Care) to municipalities, hospitals, and care homes in Norway, Sweden, Finland, Iceland, Canada, and the USA, serving 40,000+ patients across 250+ organizations.
- Company typePrivate
- Founded2012
- HeadquartersKråkerøy, Norway
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Dignio does
Dignio AS, founded in 2012 and headquartered in Oslo, Norway, sells Dignio Connected Care — a CE-marked medical device software platform (MDD 93/42/EEC) that unifies remote patient monitoring, telehealth video consultations, electronic medication dispensing, and clinical data management in a single product. The platform centers on two components: Dignio Prevent, the clinician administration console for managing patients, alerts, and dispenser fleets, and MyDignio, the patient-facing mobile/tablet application. It integrates with over 20 Bluetooth-enabled medical sensors (blood pressure, glucose, pulse oximetry, etc.) and two proprietary medication dispensers — Karie Duo (pouch-based, RFID + camera) and Mobili (cassette-based) — the former via the wholly-owned AceAge Inc. subsidiary acquired in 2022 in Ontario, Canada. Infrastructure runs on AWS Europe (Stockholm for EU/EEA, London for UK) under ISO 27001, ISO 13485, and IEC 62304 compliance.
Dignio monetizes primarily through multi-year enterprise software subscriptions sold to Norwegian and international municipalities, hospitals, and care homes, supplemented by hardware sales of its Karie Duo and Mobili dispensers. GTM is direct enterprise field sales into public procurement processes; no self-serve channel exists. Customer segments are vertically organized: primary care municipalities (200+ Norwegian municipalities, the largest segment), specialist hospitals (Oslo University Hospital, Sykehuset Østfold Kalnes, AHUS, Diakonhjemmet, Martina Hansens), and care homes (Dignio Prevent Go). Pricing is quote-based and not publicly disclosed. The company operates across six countries (Norway, Sweden, Finland, Iceland, Canada, USA) and reports 250+ organizational customers and 40,000+ patients served cumulatively.
In January 2026, Dignio was acquired by Swedish private equity firm Summa Equity through its EUR 2.3bn Fund III to fund international expansion; 2025 contracted ARR reached MNOK 180 (~60%+ YoY growth from MNOK 110) and the company achieved profitability. Management continuity was preserved, with CEO Martin Petter Fredriksen and CFO Andreas Sundby Hall remaining in post. Existing pre-acquisition investors included Monte Rosa Capital, Investinor, Fredriksborg Investor, and Stena Sessan, who had backed a MNOK 85 capital raise in 2020.
Dignio firmographics
Firmographics- Name
- Dignio
- Legal name
- Dignio AS
- Website
- https://dignio.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Dignio AS is a Norwegian health tech company that sells a CE-marked, unified remote patient monitoring and electronic medication dispensing platform (Dignio Connected Care) to municipalities, hospitals, and care homes in Norway, Sweden, Finland, Iceland, Canada, and the USA, serving 40,000+ patients across 250+ organizations.
- Ownership category
- akta.pro rank
Dignio industry classification
Industry- Product category
- Remote Patient Monitoring / Digital Health Software
- NAICS
- Health Care and Social Assistance (62)
- SIC
- Services-Health Services (8000), Surgical & Medical Instruments & Apparatus (3841), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
- akta.pro secondary industries
- Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)
Keywords
Where Dignio is headquartered
LocationHeadquarters
- HQ city
- Kråkerøy
- HQ country
- Norway
- HQ region
- Europe
Offices2 records
Markets served
Dignio business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain, Operations
Revenue model
- Software Subscription (Dignio Connected Care / Dignio Prevent): Healthcare organizations (municipalities, hospitals, care homes) pay subscription fees for the Dignio Prevent administration platform and associated patient monitoring services. This is the core recurring revenue stream.
- Medication Dispenser Hardware Sales: Dignio sells medication dispensing hardware (Karie Duo, Mobili) to healthcare providers and municipalities as part of their digital home care solution. Hardware may be bundled with the software subscription or sold separately.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise subscription for municipalities and healthcare organizations |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Dignio product offering
Product offeringCore offering
Dignio sells a CE-marked digital connected-care software platform called Dignio Connected Care, which combines remote patient monitoring, telehealth video consultations, automated medication dispensing, and clinical data management in a single integrated solution for healthcare providers. The platform is sold to municipalities, hospitals, and care institutions on a subscription basis and is complemented by proprietary medication dispenser hardware (Karie Duo, Mobili) and integrations with more than 20 Bluetooth-enabled medical measurement devices.
Product overview
Dignio offers a modular connected care platform called Dignio Connected Care, consisting of the Dignio Prevent administration platform for healthcare professionals and the MyDignio patient application. The platform integrates medication dispensers (Karie Duo and Mobili), video consultation capabilities, integrated medical sensors (20+ devices), and remote monitoring tools. Dignio Prevent Go and Dignio Care serve nursing home segments. The solution is CE-marked as a medical device under MDD directive 93/42/EØF and is designed for patients with chronic diseases and other conditions requiring home-based care follow-up.
Differentiator
Problem solved
Functional benefit
Brands
- Dignio Prevent: Clinical management platform for healthcare professionals to manage patients, medication dispensers, and remote monitoring
- MyDignio
- Karie
- Karie Duo
- Mobili
- Dignio Prevent Go
- Dignio Care
Products and services
- Dignio Connected Care (Dignio Prevent platform) CE-marked medical-device software platform (Dignio Prevent) for healthcare professionals to manage remote patient monitoring, medication dispensers, equipment, task lists, severity-prioritized alerts, and clinical decision support across primary and specialist health services. Sold via multi-year enterprise subscription to municipalities, hospitals, and care institutions.
- MyDignio patient app
Quantifiable outcome
- Cost reduction per patient per month for healthcare providers
- +8 more outcomes
Companies that use Dignio
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles3 records
Dignio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability8 records
Feature7 records
Dignio partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- AceAge Inc. (Acquisition)coreDignio acquired AceAge Inc., a Canadian manufacturer of medication dispensers, to gain control over the full value chain of electronic medication dispensing and strengthen its position as an innovator in health technology. AceAge continues to be based in Ontario, Canada, serving existing and new customers, while Dignio collaborates closely with AceAge management on continued product development.
- Amazon Web Services (AWS) EuropecoreDignio uses AWS Europe for cloud infrastructure. All customer data is stored on AWS servers in Stockholm (for EU/EØS customers) and London (for UK customers). AWS Europe is certified to ISO 27001, ISO 27017, and ISO 27018, and ensures data is not transferred outside the EØS.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
Dignio competitors and assessment
Company assessmentDirect peers
- Huma: UK-headquartered RPM and decentralized clinical trials platform serving hospitals, pharma and providers. Comparable to Dignio on the digital outpatient clinic and chronic disease monitoring use cases, and on integrating patient-reported outcomes with clinical workflows.
- Health Recovery Solutions: US-based RPM platform for hospitals and home health agencies, providing tablets, Bluetooth peripherals and clinical dashboards. Closely comparable to Dignio's sensor-integrated monitoring and clinical decision support workflow.
- Luscii: Dutch RPM platform serving hospitals and care organizations with condition-specific remote monitoring pathways (COPD, heart failure, etc.). Comparable to Dignio's hospital segment (Oslo University Hospital, AHUS, Diakonhjemmet) and its disease-specific digital outpatient clinic approach.
- Tunstall Healthcare: UK-based connected care platform offering telehealth, telecare and remote patient monitoring for elderly and chronic disease patients in their homes. Operates a B2B model selling to municipalities and care providers, very similar to Dignio's Norwegian municipal GTM and clinical/home-care use cases.
- Vivify Health (Optum / UnitedHealth Group): RPM platform for hospitals, home health and payers, offering connected care kits, patient engagement and remote monitoring. Now part of Optum — directly competes with Dignio in the integrated RPM + telehealth space, though at much larger scale and predominantly in the US.
Broad incumbents
- Resideo Life Care Solutions: RPM and connected care business (originating from Honeywell) offering remote monitoring, medication management and PERS solutions to care providers and payers. A broader incumbent with overlapping capabilities but a wider, less specialized portfolio than Dignio.
- Philips HealthSuite / Philips Remote Patient Monitoring: Broad incumbent with connected care, RPM and medication management products (including medication dispensers) sold globally to hospitals and health systems. Overlaps with Dignio's offering as part of Philips' much wider portfolio, but not a niche specialist.
Emerging players
- Hero Health: Smart in-home medication dispenser for consumers and care providers with adherence tracking and reminders. Overlaps with Dignio's medication dispenser and remote adherence monitoring offerings, though with a more consumer-leaning GTM.
- MedMinder: US smart pill dispenser and medication adherence solution for patients at home, with cellular-connected dispensers and caregiver notifications. Directly comparable to Dignio's Karie Duo / Mobili medication dispenser hardware line and adherence-monitoring use case.
- Doccla: UK-based virtual ward and RPM provider serving the NHS with end-to-end remote monitoring services. Comparable to Dignio on the integrated clinical service + technology model for hospitals and integrated care systems.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Dignio social profiles
Digital presenceDignio compliance and trust
Trust signalCompliance11 records
Dignio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dignio leadership team
Management profileNumber of profiles
Profiles8 records
Dignio subsidiaries and ownership
Company hierarchySubsidiaries1 record
Dignio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dignio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dignio
What does Dignio do?
Dignio sells a CE-marked digital connected-care software platform called Dignio Connected Care, which combines remote patient monitoring, telehealth video consultations, automated medication dispensing, and clinical data management in a single integrated solution for healthcare providers. The platform is sold to municipalities, hospitals, and care institutions on a subscription basis and is complemented by proprietary medication dispenser hardware (Karie Duo, Mobili) and integrations with more than 20 Bluetooth-enabled medical measurement devices.
Is Dignio a public or private company?
Dignio is a private company. It is classified as private equity controlled and is currently acquired.
When was Dignio founded?
Dignio was founded in 2012. It employs 11 to 50 people.
Where is Dignio based?
Dignio is headquartered in Kråkerøy, Norway, in the Europe region.
How does Dignio make money?
Two revenue lines are on record. Software Subscription (Dignio Connected Care / Dignio Prevent) is the primary driver. The others are medication Dispenser Hardware Sales.
Who are Dignio's main competitors?
Direct peers on record are Huma, Health Recovery Solutions, Luscii, Tunstall Healthcare and Vivify Health (Optum / UnitedHealth Group). Broad incumbents are Resideo Life Care Solutions and Philips HealthSuite / Philips Remote Patient Monitoring. Emerging players are Hero Health, MedMinder and Doccla.
Does Dignio have an API?
No public API is recorded for Dignio.
What industry is Dignio in?
Dignio's product category is Remote Patient Monitoring / Digital Health Software. Its primary akta.pro industry code is HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring, with a secondary code of HLACAFAH, Virtual Nursing, Telemonitoring & Command Center Platforms. Its NAICS code is 62 and its SIC code is 8000.